Branch Therapeutics develops oral cancer drugs that can treat multiple cancer types.
Branch Therapeutics has raised $4.0M in total funding. The most recent round was Seed. The last funding was announced in May 2025.
Branch Therapeutics is headquartered in Houston, United States.
Branch Therapeutics develops oral cancer drugs that can treat multiple cancer types.
Branch Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Branch Therapeutics — Funding & Investors." VCBacked, May 22, 2025, https://www.vcbacked.co/company/branch-therapeutics. Accessed September 30, 2026.
VCBacked. (2025). Branch Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/branch-therapeutics
{{cite web |title=Branch Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/branch-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated